Skip to main content

Drug Interactions between ARI Sodium Iodide (I123) 100-750 MBq and Biltricide

This report displays the potential drug interactions for the following 2 drugs:

Edit list (add/remove drugs)

Interactions between your drugs

Moderate

praziquantel sodium iodide I-123

Applies to: Biltricide (praziquantel) and ARI Sodium Iodide (I123) 100-750 MBq (sodium iodide i-123)

Praziquantel may affect the diagnostic results of sodium iodide I-123. Talk to your doctor before you are scheduled for testing to find out if and for how long you should stop using praziquantel so that it does not interfere with sodium iodide I-123 test results. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Switch to professional interaction data

Drug and food interactions

Moderate

praziquantel food

Applies to: Biltricide (praziquantel)

Food can enhance the levels of praziquantel in your body. To ensure maximal oral absorption, praziquantel should be administered with or immediately after a meal. This will make it easier for your body to absorb the medication. If you are receiving therapy with praziquantel you should avoid grapefruits and grapefruit juice. Grapefruit can raise the levels of praziquantel in your body and increase side effects of dizziness, abdominal discomfort, and nausea.. Do not increase or decrease the amount of grapefruit products in your diet without first talking to your doctor.

Switch to professional interaction data

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.


Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.